Skip to main contentSkip to navigation
Sirius Investors
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

SRNE
OTCHealthcare

SRNE Financial Statements & Analysis

Complete financial statements for SRNE including income statement, balance sheet, and cash flow statement. Analyze SRNE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
5.9%
Net Income
18.5%
Gross Margin
-2.8%
Operating Margin
8.4%

Balance Sheet

Current Ratio
-17.4%
Debt to Equity
30.8%
Asset Turnover
6.7%

Cash Flow

Operating Cash Flow
9.7%
Net Cash Flow
99.2%
Free Cash Flow
10.3%
Cash Flow to Debt
20.2%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '23TTM Q2 '23ChangeImpact
Revenue60.71M64.27M5.9%
Gross Profit27.83M28.64M2.9%
Operating Income-478.00M-463.35M3.1%
Net Income-673.54M-549.21M18.5%
EPS-0.37-0.2824.6%
EBITDA-642.25M-527.87M17.8%
Gross Margin45.84%44.56%2.8%
Operating Margin-787.39%-720.94%8.4%
Net Income Margin-1109.52%-854.53%23.0%
R&D Expenses201.31M186.11M7.5%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '23TTM Q1 '23TTM Q4 '22TTM Q3 '22TTM Q2 '22
Revenue64.27M60.71M62.84M
Gross Profit28.64M27.83M29.39M
Operating Income-463.35M-478.00M-478.53M
Net Income-549.21M-673.54M-574.74M
EPS-0.28-0.37-0.35
EBITDA-527.87M-642.25M-536.93M
Gross Margin44.56%45.84%46.77%
Operating Margin-720.94%-787.39%-761.51%
Net Income Margin-854.53%-1109.52%-914.61%
R&D Expenses186.11M201.31M221.48M

Our detailed financial analysis helps investors understand SRNE's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track SRNE's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into SRNE's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Sorrento Therapeutics, Inc. (SRNE) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors